Personal Overview
Ecosystem Preferences
About
Dr. Anupam Gupta is the Founder–Chairman of Clement MedLife Solutions Pvt. Ltd., with over three decades of sustained, research-driven medical innovation focused on diseases with high unmet clinical need.
At the center of the company’s portfolio is the Kidney Reversal / Renal Recovery program, a flagship innovation addressing one of the most complex and resource-intensive disease burdens globally—chronic kidney disease (CKD) and dialysis dependency.
The Kidney Reversal program has reached an advanced in-human proof-of-concept stage.
From a market perspective, the Kidney Reversal program targets a global renal care opportunity exceeding USD 300 billion annually.
To support global credibility, regulatory alignment, and investor readiness, Clement MedLife has engaged strategic ecosystem partners VCLS from Europe and Admare from Canada.
Beyond kidney disease, Clement MedLife’s broader portfolio reflects metabolic disorders such as diabetes and its complications, chronic pain with long-acting and differentiated therapeutic approaches, HIV and immune-related conditions, and other chronic and degenerative diseases.